bodies, provide a means to compartmentalize and concentrate biochemical reactions within cells.
RATIONALE: SEs are formed by the binding of master transcription factors (TFs) at each component enhancer, and these recruit unusually high densities of coactivators, including Mediator and BRD4. Mediator is a large (~1.2 MDa) multisubunit complex that has multiple roles in transcription, including bridging interactions between TFs and RNA polymerase II (RNA Pol II). BRD4 facilitates the release of RNA Pol II molecules from the site of transcription initiation. The presence of MED1, a subunit of Mediator, and BRD4 can be used to define SEs. We reasoned that if transcriptional condensates are formed at SEs, then MED1 and BRD4 should be visualized as discrete bodies at SE elements in cell nuclei. These bodies should exhibit behaviors described for liquid-like condensates. We investigated these possibilities by using murine embryonic stem cells (mESCs), in which SEs were originally described. Because intrinsically disordered regions (IDRs) of proteins have been implicated in condensate formation, we postulated that the large IDRs present in MED1 and BRD4 might be involved.
RESULTS:
We found that MED1 and BRD4 occupy discrete nuclear bodies that occur at SEs in mESCs. These bodies exhibit properties of other well-studied biomolecular condensates, including rapid recovery of fluorescence after photobleaching and sensitivity to 1,6-hexanediol, which disrupts liquid-like condensates. Disruption of MED1 and BRD4 bodies by 1,6-hexanediol was accompanied by a loss of chromatin-bound MED1 and BRD4 at SEs, as well as a loss of RNA Pol II at SEs and SEdriven genes. The IDRs of both MED1 and BRD4 formed phase-separated liquid droplets in vitro, and these droplets exhibited features characteristic of condensates formed by networks of weak protein-protein interactions. The MED1-IDR droplets were found to concentrate BRD4 and RNA Pol II from transcriptionally competent nuclear extracts, which may reflect their contribution to compartmentalizing and concentrating biochemical reactions associated with transcription at SEs in cells.
CONCLUSION:
Our results show that coactivators form phase-separated condensates at SEs and that SE condensates compartmentalize and concentrate the transcription apparatus at key cell-identity genes. These results have implications for the mechanisms involved in the control of genes in healthy and diseased cell states. We suggest that SE condensates facilitate the compartmentalization and concentration of transcriptional components at specific genes through the phase-separating properties of IDRs in TFs and cofactors. SE condensates may thus ensure robust transcription of genes essential to cell-identity maintenance. These properties may also explain why cancer cells acquire large SEs at driver oncogenes and why SEs that facilitate transcriptional dysregulation in disease can be especially sensitive to transcriptional inhibitors.
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Phase separation of coactivators compartmentalizes and concentrates the transcription apparatus. Enhancers are gene regulatory elements bound by transcription factors that recruit coactivators and the transcription apparatus (not shown) to regulate gene expression. Super-enhancers are clusters of enhancers bound by master transcription factors that concentrate high densities of coactivators and the transcription apparatus to drive robust expression of genes that play prominent roles in cell identity. This is achieved by the phase separation of coactivators, which is driven in part by high-valency and low-affinity interactions of intrinsically disordered regions. Super-enhancers (SEs) are clusters of enhancers that cooperatively assemble a high density of the transcriptional apparatus to drive robust expression of genes with prominent roles in cell identity. Here we demonstrate that the SE-enriched transcriptional coactivators BRD4 and MED1 form nuclear puncta at SEs that exhibit properties of liquid-like condensates and are disrupted by chemicals that perturb condensates. The intrinsically disordered regions (IDRs) of BRD4 and MED1 can form phase-separated droplets, and MED1-IDR droplets can compartmentalize and concentrate the transcription apparatus from nuclear extracts. These results support the idea that coactivators form phase-separated condensates at SEs that compartmentalize and concentrate the transcription apparatus, suggest a role for coactivator IDRs in this process, and offer insights into mechanisms involved in the control of key cell-identity genes.
P
hase separation of fluids is a physicochemical process by which molecules separate into a dense phase and a dilute phase. Phaseseparated biomolecular condensates, which include the nucleolus, nuclear speckles, stress granules, and others, provide a mechanism to compartmentalize and concentrate biochemical reactions within cells (1) (2) (3) . Biomolecular condensates produced by liquid-liquid phase separation allow rapid movement of components into and within the dense phase and exhibit properties of liquid droplets such as fusion and fission (4) . Dynamic and cooperative multivalent interactions among molecules, such as those produced by certain intrinsically disordered regions (IDRs) of proteins, have been implicated in liquid-liquid phase separation (5-7).
Enhancers are gene regulatory elements bound by transcription factors (TFs) and other components of the transcription apparatus that function to regulate expression of cell type-specific genes (8) (9) (10) (11) (12) (13) . Super-enhancers (SEs)-clusters of enhancers that are occupied by exceptionally high densities of transcriptional machineryregulate genes with especially important roles in cell identity (14, 15) . DNA interaction data show that enhancer elements in the clusters are in close spatial proximity with each other and the promoters of the genes that they regulate (16) (17) (18) , consistent with the notion of a dense assembly of transcriptional machinery at these sites. This high-density assembly at SEs has been shown to exhibit sharp transitions of formation and dissolution, forming as the consequence of a single nucleation event (19, 20) and collapsing when concentrated factors are depleted from chromatin (21) (22) (23) (24) (25) or when nucleation sites are deleted (26) (27) (28) (29) . These properties of SEs led to the proposal that the high-density assembly of biomolecules at active SEs is due to phase separation of enriched factors at these genetic elements (30) . Here we provide experimental evidence that the transcriptional coactivators BRD4 and MED1 (a subunit of the Mediator complex) form condensates at SEs. This establishes a new framework to account for the diverse properties described for these regulatory elements and expands the known biochemical processes regulated by phase separation to include the control of cell-identity genes.
BRD4 and MED1 coactivators form nuclear puncta
The enhancer clusters that make up SEs are occupied by master TFs and unusually high densities of factors, including BRD4 and MED1, that are coactivators (31) (32) (33) (34) (35) whose presence can be used to define SEs (14, 15, 21) . We reasoned that if BRD4 and MED1 are components of nuclear condensates, then they might be visualized as discrete puncta in the nuclei of cells, and the properties of these puncta could be investigated. Fixed cell immunofluorescence (IF) with antibodies against BRD4 and MED1 in murine embryonic stem cells (mESCs) revealed nuclear puncta for both factors (Fig. 1A) . To determine whether such puncta occur in live cells, we engineered mESCs by using CRISPR-Cas9 to tag endogenous BRD4 and MED1 with monomeric enhanced green fluorescent protein (mEGFP) ( fig. S1 ). Live-cell fluorescence microscopy of the engineered mESC lines also revealed discrete nuclear puncta (Fig. 1B) . Analysis of these images showed that there were 1034 ± 130 BRD4 and 983 ± 102 MED1 puncta per nucleus (means ± SEM) (table S1 ). These results demonstrate that BRD4 and MED1 are components of puncta within the nuclei of mESCs.
SEs are associated with coactivator puncta
Several lines of evidence suggest that SEs are likely to be associated with some of the BRD4 and MED1 puncta in mESCs. ChIP-seq (chromatin immunoprecipitation followed by sequencing) data for BRD4 and MED1 show that SEs are especially enriched in these coactivators (14, 15) . DNA interaction data suggest that SE constituents occupied by BRD4 and MED1 are in close spatial proximity to one another ( Fig. 1C and fig. S2A ). Co-occupancy of the genome by BRD4 and MED1 is most evident at SEs ( fig. S2B) (14, 15) . To determine whether SEs are associated with some of the BRD4 and MED1 puncta, we performed IF for BRD4 or MED1 together with DNA-FISH or nascent RNA-FISH for the genomic region containing the Nanog gene and its SEs (FISH, fluorescence in situ hybridization) (Fig. 1, D to G) . We found that BRD4 and MED1 puncta consistently overlapped the DNA-FISH foci (Fig. 1D) or RNA-FISH foci (Fig. 1F ). An average image analysis (details are given in the methods) of the BRD4 and MED1 IF signals centered at DNA-FISH foci (n = 137 for BRD4 and 125 for MED1) and RNA-FISH foci (n = 121 for BRD4 and 181 for MED1) revealed that, on average, BRD4 and MED1 fluorescence intensities are most enriched at the center of FISH foci ( Fig. 1 , E and G); this trend was not observed for average images centered at randomly selected nuclear positions ( and BRD4 puncta ( fig. S4G ). These results indicate that both BRD4 and MED1 puncta are present at SEs.
Coactivator puncta exhibit liquid-like rates of fluorescence recovery after photobleaching
We next sought to examine whether BRD4 and MED1 puncta exhibit features characteristic of liquid-like condensates. A hallmark of liquid-like condensates is internal dynamical reorganization and rapid exchange kinetics (1-3), which can be interrogated by measuring the rate of fluorescence recovery after photobleaching (FRAP). To study the dynamics of BRD4 and MED1 foci in live cells, we performed FRAP experiments on endogenously tagged mEGFP-BRD4 or mEGFP-MED1 cell lines. After photobleaching, mEGFP-BRD4 and mEGFP-MED1 puncta recovered fluorescence on a time scale of seconds ( Fig. 2 , A to D), with apparent diffusion coefficients of 0.37 ± 0.13 and~0.14 ± 0.04 mm 2 /s, respectively. These values are similar to those previously reported for components of liquid-like condensates (36, 37) . Adenosine triphosphate (ATP) has been implicated in promoting condensate fluidity by driving energy-dependent processes and/or through its intrinsic hydrotrope activity (38, 39) . Depletion of cellular ATP by glucose deprivation and oligomycin treatment altered fluorescence recovery after photobleaching for both mEGFP-BRD4 and mEGFP-MED1 foci; the rate of recovery for MED1 was reduced, and the extent of recovery for BRD4 was diminished (Fig. 2, E to H). These results indicate that puncta containing BRD4 and MED1 have liquid-like properties in cells, consistent with previously described phase-separated condensates.
Coactivator puncta and SE occupancy are sensitive to condensate perturbation To further investigate the biophysical properties of BRD4 and MED1 puncta, we investigated their sensitivity to 1,6-hexanediol, a compound known to disrupt liquid-like condensates, possibly by disruption of hydrophobic interactions (40) . We found that treatment of mESCs expressing endogenously tagged mEGFP-BRD4 or mEGFP-MED1 Sabari et al., Science 361, eaar3958 (2018) 27 July 2018
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To determine the effect of 1,6-hexanediol on BRD4, MED1, and RNA polymerase II (RNA Pol II) occupancy at enhancers and genes, ChIP-seq was performed with antibodies against these proteins in untreated or 1,6-hexanediol-treated mESCs. Treatment with 1,6-hexanediol caused a reduction in all three proteins at enhancers, with the most profound effects occurring at SEs (Fig. 3,  C and D, and fig. S5A ). For example, at the Klf4 SE, the levels of BRD4 were reduced by 44%, those of MED1 by 80%, and those of RNA Pol II by 56% (Fig. 3C) . Similar effects were observed genome-wide, where reductions in BRD4, MED1, and RNA Pol II were substantially larger at SEs than at typical enhancers (Fig. 3D) , and the degrees to which BRD4 and MED1 were lost from SEs were positively correlated ( fig. S5B) . These results are consistent with the notion that BRD4 and MED1 form condensates at SEs that are sensitive to 1,6-hexanediol.
The level of RNA Pol II occupancy across gene bodies can be used as a measure of transcriptional output (41) . The ChIP-seq data revealed that the reduction in BRD4 and MED1 occupancy at SEs was associated with a loss of RNA Pol II occupancy across SE-associated gene bodies (Fig. 3, C and E,  and fig. S5A ). When genes were ranked by the extent to which RNA Pol II was lost upon 1,6-hexanediol treatment, SE-associated genes were highly enriched among those that lost the most RNA Pol II (Fig. 3F) . These results are consistent with the idea that BRD4 and MED1 condensates are associated with SEs and that loss of condensate integrity adversely affects transcription.
IDRs of BRD4 and MED1 phase-separate in vitro BRD4 and MED1 contain large IDRs (Fig. 4A ) and share features with the IDRs of several proteins known to facilitate condensate formation condensate formation form phase-separated droplets in vitro (7, 36, 37, 42), so we investigated whether the IDRs of BRD4 or MED1 form such droplets in vitro. Purified recombinant mEGFP-IDR fusion proteins (BRD4-IDR and MED1-IDR) (Fig. 4B ) were added to buffers containing 10% PEG-8000 (polyethylene glycol, molecular weight 8000; materials and methods), turning the solution opaque, whereas equivalent solutions with mEGFP alone remained clear (Fig. 4C) . Fluorescence microscopy of the opaque MED1-IDR and BRD4-IDR solutions revealed GFP-positive, micronsized spherical droplets freely moving in solution (Movies 1 and 2) and falling onto and wetting the surface of the glass coverslip, where they remained stationary (Movie 3). As determined by aspect ratio analysis, the MED1-IDR and BRD4-IDR droplets were highly spherical ( fig. S6A ), a property expected for liquid-like droplets (1-3). Phase-separated droplets typically scale in size according to the concentration of components in the system (43) . We performed the droplet formation assay with varying concentrations of BRD4-IDR, MED1-IDR, and mEGFP, ranging from 0.625 to 20 mM. BRD4-IDR and MED1-IDR formed droplets with concentration-dependent size distributions, whereas mEGFP remained diffuse in all conditions tested (Fig. 4D and fig. S6B ). Although these droplets were smaller at lower concentrations, we observed BRD4-IDR and MED1-IDR droplets at the lowest concentration tested (0.625 mM) ( fig. S6C) .
To investigate the biophysical properties of these droplets, we tested their ability to form under varying salt concentrations (to probe the contribution of electrostatic interactions) or upon 1,6-hexanediol treatment (to probe the contribution of hydrophobic interactions). The size distributions of both BRD4-IDR and MED1-IDR droplets shifted toward smaller droplets with increasing NaCl concentration (from 50 to 350 mM) (Fig. 4E and fig. S6D ), and opacity was reduced with 10% 1,6-hexanediol treatment ( fig. S7A ). These results demonstrate that a variety of molecular interactions contribute to BRD4-IDR and MED1-IDR droplet formation.
We next sought to test whether the droplets are irreversible aggregates or reversible phaseseparated condensates. To do this, BRD4-IDR and MED1-IDR were allowed to form droplets in an initial solution. The protein concentration was then diluted by half in equimolar salt or in Sabari et al., Science 361, eaar3958 (2018) 27 July 2018
6 of 11 Blue light stimulation a higher salt solution (Fig. 4F) . The preformed BRD4-IDR and MED1-IDR droplets were reduced in size and number with dilution and even further reduced with elevated salt concentration (Fig. 4F  and fig. S7B ). These results show that the BRD4-IDR and MED1-IDR droplets form a distribution of sizes that is dependent on the conditions of the system and, once formed, respond to changes in the system, with rapid adjustments in size. These features are characteristic of phase-separated condensates formed by networks of weak proteinprotein interactions (1-3).
MED1-IDR participates in liquid-liquid phase separation in cells
To investigate whether the coactivator IDRs facilitate phase separation in cells, we used a previously developed assay to manipulate local protein concentrations within the cell; this optoIDR assay tests IDR-dependent, light-inducible droplet formation in vivo (44) . Briefly, the photoactivatable, self-associating Cry2 protein was labeled with mCherry and fused to an IDR of interest. This fusion mediates a blue lightinducible increase in the local concentration of selected IDRs within the cell (Fig. 5A ) (44) . In this assay, IDRs known to promote phase separation enhance the photoresponsive clustering properties of Cry2 (45, 46) , causing rapid formation of liquid-like spherical droplets under stimulation by blue light. Fusion of a portion of the MED1-IDR to Cry2-mCherry facilitated the rapid formation of micron-sized spherical droplets upon blue light stimulation (optoDroplets) (Fig. 5, B and C, and fig. S8 ). During stimulation, proximal droplets were observed to fuse (Fig. 5, D and E, and Movie 4). The fusions exhibited characteristic liquid-like fusion properties of necking and relaxation to spherical shape (Fig.  5E ). The MED1-IDR droplets persisted after blue light stimulation and exhibited liquid-like FRAP recovery rates in the absence of blue light stimulation (Fig. 5, F to H) . The rapid FRAP kinetics in the absence of light-activated Cry2 interactions suggests that the MED1-IDR optoDroplets established by blue light are dynamic assemblies exchanging with the dilute phase.
Conserved serine bias in the MED1-IDR is necessary for phase separation
Previous studies have implicated low-complexity IDRs of proteins in liquid-liquid phase separation (7, 36, 37, 42) . An examination of the amino acid content of MED1 revealed that the IDR contains a compositional bias for serine (Fig. 6A) . This serine compositional bias is conserved among vertebrates (Fig. 6B) . To investigate whether the serine bias is necessary for the MED1-IDR's capacity to phase-separate, we mutated all the serine (S) residues to alanine (A) and investigated the ability of this mutated IDR to form phaseseparated droplets in vitro. The MED1-IDR S-to-A mutant was incapable of forming phase-separated droplets under conditions in which the wild-type IDR readily formed droplets (Fig. 6C) , indicating that the conserved serine bias in the MED1-IDR is necessary for droplet formation.
MED1-IDR droplets can incorporate proteins necessary for transcription
A proposed function of phase separation at SEs is the ability to compartmentalize and concentrate factors within a biomolecular condensate, so we sought to test whether MED1-IDR droplets could recapitulate this compartmentalization function in vitro. We identified conditions under which the MED1-IDR could form droplets but the BRD4-IDR could not ( fig. S9 ). We then investigated whether the MED1-IDR droplets could compartmentalize BRD4-IDR protein under these conditions (Fig. 7A) . Using differentially labeled proteins (mCherry-MED1-IDR and mEGFP-BRD4-IDR), we found that the MED1-IDR droplets could incorporate, and thus concentrate, the BRD4-IDR protein (Fig. 7A) . The MED1-IDR droplets did not incorporate mEGFP (Fig. 7A) . To probe the approximate mesh size of the MED1-IDR droplets (47), we incubated them with fluorescently labeled dextrans with average molecular weights of 4, 10, and 40 kDa. We found that the 4-kDa dextrans were incorporated into the MED1-IDR droplets, the 10-kDa dextrans were incorporated with less efficiency, and the 40-kDa dextrans were excluded ( fig. S10 ). These results suggest that the incorporation of mEGFP-BRD4-IDR (105 kDa) into the MED1-IDR droplet is due to attractive molecular interactions, as opposed to passive diffusion through the droplet mesh. We next investigated whether the MED1-IDR, introduced into a transcription-competent nuclear extract, would form droplets that might incorporate BRD4 or other transcriptional components. We found that the wild-type MED1-IDR, but not the MED1-IDR S-to-A mutant, formed droplets in these extracts (Fig. 7B) . The MED1-IDR phase-separated droplets were denser than the surrounding extract and thus could be purified from solution by centrifugation. Immunoblot analysis revealed that BRD4 and the largest subunit of RNA Pol II (RPB1) were enriched in pelleted droplets in a MED1-IDR dose-dependent manner (Fig. 7C) . These results indicate that the MED1-IDR droplets can incorporate BRD4 and RNA Pol II.
The ability of the MED1-IDR protein to incorporate BRD4 and RNA Pol II into an artificial phase-separated compartment suggests that it sequesters key components of the transcription apparatus and might thus "squelch" transcription in the nuclear extract. We carried out an in vitro transcription assay with these extracts and found that the wild-type MED1-IDR protein does squelch transcription, correlating with the amount of material separated from solution by the MED1-IDR droplets (Fig. 7D) . We did not observe these effects with equivalent concentrations of mEGFP or with the MED1-IDR S-to-A mutant (Fig. 7D ). These results demonstrate that the MED1-IDR has the capacity to compartmentalize and concentrate transcriptional machinery from a complex nuclear extract.
Discussion
SEs regulate genes with prominent roles in healthy and diseased cellular states (14, 15, 19-25, 48, 49 transcription. Within these condensates, BRD4 and MED1 exhibit apparent diffusion coefficients similar to those previously reported for other proteins in phase-separated condensates in vivo (36, 37) . The IDRs of both BRD4 and MED1 are sufficient to form phase-separated droplets in vitro, and the MED1-IDR facilitates phase separation in living cells. Droplets formed by MED1-IDR are capable of concentrating transcriptional machinery in a transcriptionally competent nuclear extract. These results support a model in which transcriptional coactivators form phase-separated condensates that compartmentalize and concentrate the transcription apparatus at SE-regulated genes and identify SE components that likely play a role in phase separation.
SEs are established by the binding of master TFs to enhancer clusters (14, 15) . These TFs typically consist of a structured DNA-binding domain and an intrinsically disordered transcriptional activation domain (50) (51) (52) . The activation domains of these TFs recruit high densities of many transcription proteins, which, as a class, are enriched for IDRs (53) . Although the exact client-scaffold relationship (54) between these components remains unknown, it is likely that these protein sequences mediate weak multivalent interactions, thereby facilitating condensation. We propose that condensation of such high-valency factors at SEs creates a reaction crucible within the separated dense phase, where high local concentrations of the transcriptional machinery ensure robust gene expression.
The nuclear organization of chromosomes is likely influenced by condensates at SEs. DNA interaction technologies indicate that the individual enhancers within the SEs have exceptionally high interaction frequencies with one another (16) (17) (18) , consistent with the idea that condensates draw these elements into close proximity in the dense phase. Several recent studies suggest that SEs can interact with one another and may also contribute in this fashion to chromosome organization (55, 56) . Cohesin, an SMC (structural maintenance of chromosomes) protein complex, has been implicated in constraining SE-SE interactions because its loss causes extensive fusion of SEs within the nucleus (56) . These SE-SE interactions may be due to a tendency of liquid-phase condensates to undergo fusion (1-3) .
The model whereby phase separation of coactivators compartmentalizes and concentrates the transcription apparatus at SEs and their regulated genes, described here and corroborated by (57) , raises many questions. How does condensation contribute to regulation of transcriptional output? A study of RNA Pol II clusters, which may be phase-separated condensates, suggests a positive correlation between condensate lifetime and transcriptional output (58) . What components drive formation and dissolution of transcriptional condensates? Our studies indicate that BRD4 and MED1 likely participate, but the roles of DNA-binding TFs, RNA Pol II, and regulatory RNAs require further study. Why do some proteins, such as HP1a, contribute to phase-separated heterochromatin condensates (59, 60) and others contribute to euchromatic condensates? The rules that govern partitioning into specific types of condensates have begun to be studied (61) (62) (63) (64) (65) and will need to be defined for proteins involved in transcriptional condensates. Does condensate misregulation contribute to pathological processes in disease, and will new insights into condensate behaviors present new opportunities for therapy? Mutations within IDRs and misregulation of phase separation have already been implicated in a number of neurodegenerative diseases (66) (67) (68) . Tumor cells have exceptionally large SEs at driver oncogenes that are not found in their cell of origin, and some of these are exceptionally sensitive to drugs that target SE components (22) (23) (24) (25) principles established in physics and chemistry to more effectively improve our understanding of this form of regulatory biology? Addressing these questions at the crossroads of physics, chemistry, and biology will require collaboration across these diverse sciences.
Methods summary
Immunofluorescence against BRD4 and MED1, coupled with DNA-FISH or RNA-FISH against SEs or SE-driven nascent transcripts, was performed in mESCs to visualize the colocalization between BRD4 or MED1 puncta and SEs.
BRD4 and MED1 were endogenously tagged with mEGFP in mESCs to visualize the organization of BRD4 and MED1 and to study their dynamics by FRAP and drug treatments in live cells. ChIPseq was performed to investigate the effect of 1,6-hexanediol treatment on the chromatin occupancy of BRD4, MED1, and RNA Pol II. Recombinant BRD4-IDR and MED1-IDR were purified to test their capacity to phase-separate in vitro. The optoIDR assay (45) was implemented to test the capacity of a section of MED1-IDR to phaseseparate in live cells. Mutations were introduced into MED1-IDR to study the sequence determinants of MED1-IDR phase separation. BRD4-IDR and MED1-IDR fused to different fluorescent tags were used to demonstrate the capacity of MED1-IDR droplets to compartmentalize and concentrate BRD4-IDR. Formation of MED1-IDR droplets in a transcriptionally competent nuclear extract was used to study the ability of MED1-IDR droplets to compartmentalize and concentrate BRD4 and RNA Pol II from a complex extract. In vitro transcription assays were used to measure the effect of synthetic droplet formation on transcription. All procedures are described in detail in the supplementary materials. (68) with minor modifications (full details are given in the methods). A proposed model of molecular interactions taking place within MED1-IDR droplets in nuclear extract and the impact on the in vitro transcription reaction is illustrated on the right.
